Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT04999605
Status:
TERMINATED
Last Update Posted:
2024-01-05
First Post:
2021-04-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer
Sponsor:
Akeso
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-29
First Submit QC Date:
None
Study First Post Date:
2021-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-03
Last Update Post Date:
2024-01-05
Last Update Post Date Type:
ACTUAL